▲ Peaking
Health
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Nordisk
13 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Business
Novo Nordisk Will Use Anthropic’s Claude for Drug Research
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
No more Nordisk as Novo goes it alone amid rebranding push
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Novo Nordisk Slims Down Name to Novo
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
Novo Nordisk’s once‑dominant GLP‑1 weight‑loss line now faces a fierce showdown with Eli Lilly, sparking questions about Europe’s biotech edge.
◼ Archived
Business
🔮 fades ✓
Novo Nordisk Stock Bounces Back After Surprise Earnings Report
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Novo Nordisk rocked by late-stage cardiovascular drug failure
Pharmaceutical giant Novo Nordisk faces a significant setback following the failure of a late-stage cardiovascular drug trial.
◼ Archived
Business
🔮 fades ✓
Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 holds
Hacking group claims major hack of Novo Nordisk and attempted $25 million extortion
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.